Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epidemiology and risk factors.

H T Lynch1, P Watson, J F Lynch

  • 1Department of Preventive Medicine, Creighton University School of Medicine, Omaha, NE 68178.

Clinical Obstetrics and Gynecology
|December 1, 1989
PubMed
Summary

Hereditary breast cancer (HBC) affects 9% of patients. Developing genetic biomarkers for early detection in families can improve targeted surveillance and potentially prevent breast cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Southwestern Athabaskan genetic diseases.

Genetics in medicine : official journal of the American College of Medical Genetics·2001
Same author

Family information service and hereditary cancer.

Cancer·2001
Same author

Current status of prophylactic surgery for hereditary breast and gynecologic cancers.

Current opinion in obstetrics & gynecology·2001
Same author

Parental communication of BRCA1/2 genetic test results to children.

Patient education and counseling·2001
Same author

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families.

Gastroenterology·2000
Same author

E-cadherin mutation-based genetic counseling and hereditary diffuse gastric carcinoma.

Cancer genetics and cytogenetics·2000

Area of Science:

  • Oncology
  • Genetics
  • Public Health

Background:

  • Hereditary breast cancer (HBC) constitutes a significant portion of the overall breast cancer burden.
  • Approximately 9% of breast cancer cases are hereditary, impacting numerous families.
  • The distinct natural history of HBC allows for the identification of high-risk individuals.

Purpose of the Study:

  • To emphasize the need for developing sensitive and specific biomarkers for genetic status in hereditary breast cancer.
  • To advocate for targeted surveillance and management strategies for at-risk individuals and families.
  • To explore the potential for pharmacologic research and cancer prevention through gene identification.

Main Methods:

  • Review of existing data on hereditary breast cancer prevalence and impact.
  • Discussion of the potential for biomarker development and genetic testing.
  • Analysis of the need for cost-benefit research for surveillance strategies.

Main Results:

  • HBC represents a substantial health burden, with significant implications for families.
  • Current surveillance strategies are resource-intensive and could be optimized.
  • Biomarker development is crucial for accurate risk assessment and targeted interventions.

Conclusions:

  • Development of reliable biomarkers for hereditary breast cancer is a high priority.
  • Accurate genetic identification will enable cost-effective, targeted surveillance.
  • Further research into gene cloning and associated products could lead to improved breast cancer prevention and treatment.

Related Experiment Videos